DV
Dividend Vision

LXRX — Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. (LXRX)

Total return is -98.2% over the past 26.4 years, 814.3 points behind SPY at 716.1%. Its deepest 1-year drawdown was 34.1%.

LXRX is a single-stock equity position in Lexicon Pharmaceuticals, a healthcare company focused on drug discovery and development. The holding does not pay distributions and carries no stated expense ratio as it is an individual stock rather than a diversified fund. This equity position appeals primarily to growth-oriented investors seeking exposure to the pharmaceutical and biotechnology sector rather than income-focused investors.

LXRX key facts

Asset type
Stock
Asset class
Equity
Inception date
04/07/2000
Distribution frequency
None
Last close
$2.32
Market cap
$1,032,297,728
Average volume
1762700.0
Beta
1.035
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.16